GENE ONLINE|News &
Scientists Jointly Urge FDA to Evaluate T-Cell Response in Review of COVID-19 Vaccines
More than 60 scientists have signed a letter to the U.S. Food and Drug Administration (FDA), requesting that in addition to measuring antibodies after vaccination, the agency should also focus on measuring T-cell responses to help make more accurate, long-term assessments of vaccine effectiveness and to make effective preventive decisions before new mutations of SARS-CoV-2 occur.
It's free! Log in now to read
LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
